ReviewDiabetologia2025
Targeting the NLRP3 inflammasome-IL-1β pathway in type 2 diabetes and obesity.
Daniel T Meier et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
64 papers cite itlatest 60 shown
this paperpooled ittrialcites it